IRT’s Role in Clinical Trial Continuity

Andrew Rohrbaugh, Vice President, Strategic Solutions As the Coronavirus (COVID-19) pandemic continues to impact clinical trials globally, we have seen a significant shift in focus to trial continuity – identifying ways to ensure that existing study participants are able to continue receiving investigational product, and maintain their participation in an ongoing clinical trial. Distribution vendors…